Learning to Love Big Pharma

Coronavirus continues its terrifying rampage of large swaths of the country. But the Trump administration has made a point of mentioning that even while cases are rising, deaths are declining. That disconnect is, he says, proof the Covid-19 pandemic is under control. But the mism ...  Show more

The U.S. is home to the highest number of Covid-19 cases—2.6 million and counting—and the most deaths. The reasons for that are at least, in part, very American ones: Politicized science, a fragmented media landscape, and inequality. Executive Editor Brian Bremner reflects on how ...  Show more

As a number of existing therapies are being re-purposed to help patients with the most severe Covid-19 symptoms, we speak to a UK-based bioscience company about a drug they've developed and explore how it is being used in Italy. Guests: Tom Whipple, The Times science editorSomeit ...  Show more

The founders of German biotechnology company BioNTech were researching how to fight cancers using messenger RNA, "the unloved cousin of DNA", when covid-19 first appeared and they realised mRNA could be used to make a vaccine for the disease. Financial Times journalist Joe Miller ...  Show more

It’s February 2020 and drugmaker Moderna’s sprinting ahead – its Covid vaccine is already poised to enter human trials.But Moderna and its rivals know plenty of vaccines never make it out of trials alive. It’s also going to take a lot of manufacturing muscle to inoculate the worl ...  Show more

Scientists are racing to make a vaccine for the coronavirus, collaborating across borders in what is usually a secretive and competitive field. But their cooperation has been complicated by national leaders trying to buy first claim on any breakthrough. Today, we explore how t ...